- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01907204
Evaluation of Inhaled Treatment in Sinusitis
January 24, 2014 updated by: G.Reychler, Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Evaluation of Inhaled Corticosteroid Treatment in Sinusitis
The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Phase 2
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Nasal/Sinus polyps
Exclusion Criteria:
- Previous sinus surgery
- Age under 18y
- Use of antibiotics
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Oral
Oral drug (methylprednisolone) administration
|
Oral 32mg/8d-16mg/4d-8mg/4d
|
|
Experimental: Metered dose inhaler
|
Budesonide by metered dose inhaler
Budesonide by nebulization
|
|
Experimental: Nebulized
|
Budesonide by metered dose inhaler
Budesonide by nebulization
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Sniffin' Sticks Test
Time Frame: Baseline and day 15
|
Baseline and day 15
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Specific quality of life questionnaire (Snot 20)
Time Frame: Baseline and day 15
|
Baseline and day 15
|
|
Retro Olfaction Test
Time Frame: Baseline and day 15
|
Baseline and day 15
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Gregory Reychler, PhD, Cliniques universitaires Saint-Luc
- Study Director: Philippe Rombaux, Prof PhD, Cliniques universitaires Saint-Luc
- Principal Investigator: Coralie Colbrant, PT, Cliniques universitaires Saint-Luc
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
July 12, 2013
First Submitted That Met QC Criteria
July 18, 2013
First Posted (Estimate)
July 24, 2013
Study Record Updates
Last Update Posted (Estimate)
January 27, 2014
Last Update Submitted That Met QC Criteria
January 24, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Otorhinolaryngologic Diseases
- Paranasal Sinus Diseases
- Nose Diseases
- Sinusitis
- Physiological Effects of Drugs
- Autonomic Agents
- Peripheral Nervous System Agents
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antiemetics
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Neuroprotective Agents
- Protective Agents
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Prednisolone
- Methylprednisolone Acetate
- Methylprednisolone
- Methylprednisolone Hemisuccinate
- Prednisolone acetate
- Prednisolone hemisuccinate
- Prednisolone phosphate
- Budesonide
Other Study ID Numbers
- Sinusitis001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.